Mon, 03 Dec 2018 20:25:49 GMT
GSK shares decline after acquisition announcement
After GlaxoSmithKline announced the acquisition of the cancer specialist Tesaro, the company's shares began to decline. The reason for the decline was that the company is paying a 110 percent premium on the acquisition and takes on Tesaro's debt.